Abstract #4222

Differentiation between hepatocellular carcinoma (HCC) and hepatic metastasis (HM) by mDIXON quant and IVIM imaging

Xue Ren¹, Jiazheng Wang², Liangjie Lin², Zhigang Wu², Qingwei Song¹, Renwang Pu¹, Lihua Chen¹, Ying Zhao¹, Tao Lin¹, Qihao Xu¹, and Ailian Liu¹

¹Department of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian, China, ²Philips Healthcare, Beijing, China

Synopsis

Hepatocellular carcinoma (HCC) and hepatic metastasis (HM) are associated with distinct treatment and prognosis, while the differential diagnosis of HCC and HM still remains challenging. This study aims to explore the value of mDIXON quant and IVIM imaging in the differential diagnosis of HCC and HM. Results shown that the combination of R2*and IVIM measurements may offer a good biomarker for differential diagnosis of HCC and HM.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.